Bharat Seats Limited has reported its audited financial results for the quarter and year ended March 31, 2026. The company's total income from operations for the full year stood at ₹1,95,623.38 lakhs, while net profit after tax increased to ₹4,223.12 lakhs from ₹3,270.03 lakhs in the previous year. The board has recommended a dividend of 75%, or ₹1.50 per equity share, subject to shareholder approval.

Full-Year Financial Performance

For the year ended March 31, 2026, the company recorded a total comprehensive income of ₹4,201.52 lakhs. Other equity as shown in the audited balance sheet stood at ₹21,709.99 lakhs, with equity share capital remaining stable at ₹1,256.00 lakhs. Basic and diluted earnings per share (EPS) for the year were ₹6.72.

The following table presents the key financial metrics for the year ended March 31, 2026, alongside comparative figures:

Quarterly Highlights

For the quarter ended March 31, 2026, total income from operations was ₹57,485.11 lakhs, compared to ₹49,195.67 lakhs in the preceding quarter and ₹39,419.42 lakhs in the corresponding quarter of the previous year. Net profit after tax for the quarter stood at ₹1,325.31 lakhs, against ₹990.04 lakhs in Q3 FY26 and ₹1,138.85 lakhs in Q4 FY25.

Board Decisions and Future Outlook

The Board of Directors, at their meeting held on May 06, 2026, approved the audited financial results and recommended a final dividend of ₹1.50 per share. The record date for the dividend is July 17, 2026. Additionally, the board approved capital expenditure of approximately ₹86.61 crores for new programs of Maruti Suzuki India Limited at the company's plants in Kharkhoda and Gujarat Navyani. The 39th Annual General Meeting is scheduled for July 24, 2026.

Bharat Seats Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026, following a Board of Directors meeting held on May 6, 2026. The board approved the annual financial statements, recommended a final dividend, sanctioned capital expenditure for new programmes, and fixed the date for the 39th Annual General Meeting. The financial results were reviewed by the Audit Committee and approved by the Board, with an unmodified opinion issued by statutory auditors M/s S.R. Batliboi & Co., LLP, Chartered Accountants.

Financial Performance

Bharat Seats delivered strong revenue and profit growth for the full financial year. Revenue from operations rose to ₹1,95,095.14 lakhs from ₹1,28,882.47 lakhs in the previous year. Total income for the year stood at ₹1,95,623.38 lakhs compared to ₹1,29,241.04 lakhs previously. Net profit for the year grew to ₹4,223.12 lakhs from ₹3,270.03 lakhs, while total comprehensive income for the year was ₹4,201.52 lakhs against ₹3,275.03 lakhs in the prior year. Basic and diluted earnings per share (EPS) for the full year stood at ₹6.72, up from ₹5.21. For Q4, the company reported net profit of 132M rupees versus 114M rupees in the same quarter of the previous year, on revenue of 5.74B rupees compared to 3.93B rupees year-on-year. Q4 EBITDA stood at 296M rupees versus 227M rupees year-on-year, with EBITDA margin at 5.17% compared to 5.78% in the prior-year quarter.

The following table summarises the key financial metrics:

The table below captures Q4 EBITDA performance:

Balance Sheet Highlights

As at March 31, 2026, total assets stood at ₹73,665.04 lakhs compared to ₹64,770.38 lakhs as at March 31, 2025. Total equity increased to ₹22,965.99 lakhs from ₹19,455.27 lakhs. Cash and cash equivalents at year-end rose to ₹1,530.86 lakhs from ₹295.58 lakhs. Net cash flow from operating activities for the year was ₹10,670.87 lakhs, while net cash used in investing activities was ₹4,720.21 lakhs.

Dividend and Capital Expenditure

The Board has recommended a final dividend of 75%, amounting to ₹1.50 per equity share of face value ₹2/- each, aggregating to ₹942.00 lakhs, subject to shareholder approval at the ensuing Annual General Meeting. The record date for the purpose of dividend has been fixed as July 17, 2026. Additionally, the Board approved capital expenditure of approximately ₹86.61 crores for new programmes of Maruti Suzuki India Limited, for the company's plants at Kharkhoda and Gujarat Navyani, in the ordinary course of business.

Exceptional Item and Income Tax Matter

The financial results include an exceptional item of ₹137.37 lakhs recognised in the quarter ended December 31, 2025 and the year ended March 31, 2026, arising from the implementation of the New Labour Codes effective November 21, 2025. This amount covers incremental gratuity and compensated absences obligations. Separately, the company received demand orders from the Income Tax Department amounting to ₹2,243.72 lakhs (excluding penalties) for Assessment Years 2014-15 to 2024-25, along with a penalty demand of ₹524.28 lakhs for Assessment Year 2022-23. Following appeals, the Commissioner of Income Tax (Appeals) has reduced the demand to ₹245.25 lakhs for Assessment Years 2013-14 to 2024-25, except for Assessment Year 2022-23, for which the order is still awaited. The total demand for Assessment Year 2022-23 stands at ₹756.75 lakhs (including penalties). Management has expressed confidence in a favourable outcome, and no adjustment has been made to the financial results pending the outcome of appeal proceedings.

Director Re-appointment

The Board recommended to shareholders the re-appointment of Mr. Rishabh Relan (DIN: 07726444) as Whole Time Director for a further term of three years with effect from February 4, 2027 to February 3, 2030. Mr. Rishabh Relan, aged 35 years, has been associated with the company since August 2012 and has been Whole Time Director since February 2021. He holds a Bachelor's degree in Industrial Engineering from Georgia Institute of Technology, Atlanta, USA, and a Diploma in Six Sigma in lean manufacturing from the Institute of Industrial Engineering, United States. He is the son of Mr. Rohit Relan, Chairman and Managing Director of the company.

The board meeting commenced at 3:15 p.m. and concluded at 4:50 p.m. on May 6, 2026. The results were signed by Rohit Relan, Chairman and Managing Director, and the intimation was submitted by Ritu Bakshi, Company Secretary and Compliance Officer.